Views & Analysis | Perspectives on pharma industry issues

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Patients

pharmaphorum podcast Episode 281 - Cecilia Caetano, Bayer

Sponsored

Menopause is an urgent global health issue: Bayer’s Cecilia ...

Articles

Editor’s Voice: March – R&D innovation, data transparency an...

This month on pharmaphorum, we have seen the publication of some great R&D innovation content pieces, heated debates over data transparency and the day one of us became a published author. Is it just me or are these months flying by? We’re at the end of March already, and although the weather here in the UK may...

Articles

HCPs in the digital landscape of the Russian market

To start our digital and social media focus month, Oxana Kolosova explores the digital landscape for HCPs in Russia. Since growth in the western pharma markets came to a standstill there has been growing interest from the industry in so-called pharmerging markets...

Articles

mHealth Monthly Mashup: Release 20.0 – Regulatory update

This month’s mashup revisits the regulation of mobile health apps, and how it could impact innovation. Healthcare is a continuous battle between opposing, often complementary, forces. The tripartite war between speed, cost, and ...

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Sales & Marketing

Female pharmacist with male patient in pharmacy

Your DTP programme has five vendors and no spine

Over the past few years, many pharma brands set out to build a direct-to-patient (DTP) channel. The website went live. A telehealth partner was selected. Pharmacy logistics were set up.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital